stockrowQuest Diagnostics Incorporated (DGX) vs Natera, Inc. (NTRA)
- Quest Diagnostics Incorporated DGX 256.54 +0.71%
- Natera, Inc. NTRA 313.26 −13.88%
Quest Diagnostics Incorporated and Natera, Inc. are both Diagnostics & Research companies. Natera, Inc. is the larger, with a market value of $52.4B against $28.0B — 1.9× the size. Natera, Inc. has negative trailing earnings, so its P/E is not meaningful; Quest Diagnostics Incorporated trades at 25.0×. Natera, Inc. grew revenue faster over the last twelve months: 37.4% against 9.13%. Quest Diagnostics Incorporated has the higher net margin (9.50% vs −5.66%) and the higher return on invested capital (8.48% vs −8.35%). Across the 20 metrics below, Quest Diagnostics Incorporated leads on 15 and Natera, Inc. on 5.
Valuation
Profitability
| Metric | DGX | NTRA | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.11% | 0.00% | 48.32% |
| Operating margin | 14.55% | (8.95%) | (5.68%) |
| Net margin | 9.50% | (5.66%) | (4.10%) |
| Free cash flow margin | 11.61% | 1.80% | 0.00% |
| Return on equity | 14.76% | (10.55%) | 0.00% |
| Return on assets | 6.73% | (7.21%) | (6.05%) |
| Return on invested capital | 8.48% | (8.35%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack